SHANGHAI – Newly founded biopharma Harbour Biomed Therapeutics Ltd., of Shanghai, has acquired privately held Harbour Antibody BV, of Cambridge, Mass. The cash-and-equity deal was inked after Harbour Biomed secured $50 million in venture financing from life science investors Adventech and Legend.